Artivion | CRY - 应收帐款人

金融业

USD 21.64

USD 1.07B

现金及等价物

USD 77.32M

USD 42.85M

USD 371.38M

USD 106.93M

USD 317.78M

USD 4.79M

USD 22.72M

1.5K

EPS每股收益

USD -0.02

股本和储备

USD 445.59M

USD 73.14M

债务利息支出

USD 5.53M

USD -0.05

USD 363.42M

USD 900.4M

USD 2.42M

USD 111.2M

USD 4.79M

普通股股本

USD 47.84M

212.38

USD 11.4M

USD 115.99M

销售和管理费用

USD 55.75M

USD 103.36M

贸易债权人

USD 20.87M

应收帐款人

USD 103.68M

	应收帐款人	更改		日
Abbott	USD 11.22B		655M	2026-03
Accuray	USD 91.79M		7.07M	2024-09
AngioDynamics	USD 44.43M		1.79M	2025-09
Artivion	USD 103.68M		6.31M	2025-12
AtriCure	USD 79.98M		8.67M	2026-06
Baxter International	USD 1.86B		158M	2026-06
Becton, Dickinson and Co.	USD 2.36B		159M	2026-06
Boston Scientific	USD 3.03B		101M	2026-03
Edwards Lifesciences	USD 973M		60.9M	2026-03
Inogen	USD 37.09M		4.11M	2024-06
Integra LifeSciences	USD 267.19M		2.78M	2026-06
J&J	USD 19.05B		3.49B	2026-06
Mesa Laboratories	USD 40.23M		4.66M	2024-09
Orthofix International	USD 135.75M		4.94M	2025-12
Pfizer	USD 16.19B		19M	2026-06
ResMed	USD 1.04B		37.4M	2026-06
Stryker	USD 3.74B		172M	2026-06
Tandem Diabetes Care	USD 162.06M		21.39M	2026-06
Teleflex	USD 364.61M		917K	2026-06
Terumo	JPY 225.57B		8B	2026-06
Trinity Biotech	USD 10.28M		4.74M	2025-12